Has Mitesh Patel received payments from drug or device companies?

Yes. Drug and device makers reported $89,632 in general payments to Mitesh Patel across 171 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mitesh Patel did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mitesh Patel come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mitesh Patel

Gastroenterology · Washington, DCNPI 1063696052

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $66,063 of the $89,632 with a category attached, or 73.7%. AbbVie accounts for 93.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $52,183 and has fallen 100.0% since, to $19 in 2025. Among gastroenterology clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$89,632in general payments, 2019–2025

Across 171 payments — averaging $524.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$84K
Boston Scientific$3K
Merck$3K
Phathom Pharmaceuticals, Inc.$120
Biohaven Pharmaceuticals, Inc.$118
Johnson & Johnson$19

$23,332in research payments, 2019–2025

Across 7 payments — averaging $3333.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Novartis$23K

What the payments were for

Consulting fees$1,9502%
Speaking & faculty fees$66,06374%
Travel & lodging$16,41518%
Food & beverage$5,2056%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	123	$83,900
Boston Scientific	24	$2,770
Merck	21	$2,706
Phathom Pharmaceuticals, Inc.	1	$120
Biohaven Pharmaceuticals, Inc.	1	$118
Johnson & Johnson	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$89,632 in reported general payments places this provider in the 90th percentile of 77 gastroenterology providers in District of Columbia.

See all gastroenterology providers in District of Columbia →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Omeprazole	19	$194

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Washington

James LewisWashington$1M
John HoganWashington$354K
Mark MattarWashington$349K
Jessica KormanWashington$171K
Sumona BhattacharyaWashington$87K
Roshan BashirWashington$40K
Bruce LuxonWashington$37K
Lauren GeorgeWashington$32K
Dominique HowardWashington$29K
Vijayrama PoreddyWashington$13K

See the full list for District of Columbia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →